-

SHAREHOLDER ALERT: Robbins LLP Announces That Ebang International Holdings Inc. (EBON) is Being Sued for Misleading Shareholders

SAN DIEGO & HANGZHOU, China--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of Ebang International Holdings Inc. (NASDAQ: EBON) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between June 26, 2020 and April 5, 2021. Ebang purports to be a leading application-specific integrated circuit ("ASIC") chip design company and a leading manufacturer of Bitcoin mining machines.

If you suffered a loss due to Ebang Holdings Inc.'s misconduct, click here.

Ebang International Holdings Inc. (EBON) Misled Investors Regarding its Business Plan

According to the complaint, during the class period, Ebang failed to disclose to investors that: (i) the proceeds from Ebang's initial public offering ("IPO") in November 2020 had been direct to related parties instead of the Company's operations; (ii) Ebang had inflated reported sales, including through defective units; and (iii) its attempts to go public in Hong Kong had failed due to allegations of embezzling investor funds and inflated sales figures.

On April 6, 2021, before the market opened, Hindenburg Research reported that Ebang is directing proceeds from its IPO into a "series of opaque deals with insiders and questionable counterparties." According to the report, Ebang raised $21 million, claiming the proceeds would go "primarily for development," but instead used the funds to repay related-party loans to a relative of Ebang's CEO, Dong Hu. The report also noted that Ebang failed to go public on the Hong Kong Stock Exchange due to a sales inflation scheme with Yindou, a Chinese peer-to-peer online lending platform that defrauded 20,000 retail investors in 2018 with $655 million "vanish[ing] into thin air." The report also challenged Ebang's claim to be the leading bitcoin producer globally and noted that the Company's sales appeared to be "defective units or just fabricated altogether."

On this news, Ebang's stock price fell approximately 13%, to close at $5.53 per share on April 6, 2021. In response, Ebang issued a statement that it believed the report "contain[ed] many errors, unsupported speculations and inaccurate interpretations of events," and indicated that the Board and Audit Committee would review the allegations. The Company's stock price declined further on this news.

If you purchased shares of Ebang International Holdings Inc. (EBON) between June 26, 2020 and April 5, 2021, you have until June 7, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Ebang International Holdings Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the REGENXBIO, Inc. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired REGENXBIO, Inc. (NASDAQ: RGNX) securities between February 9, 2022 and January 27, 2026. REGENXBIO is a clinical-stage biotechnology company providing gene therapies that deliver functional genes to cells with genetic defects in the United States. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800)...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the uniQure N.V. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that un...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic diseases in China." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Alleg...
Back to Newsroom